Diagnostic Imaging for Liver Cancer

Initial Investigation

The American College of Radiology recommends abdominal ultrasound as the initial screening exam for patients at risk of liver cancer due to its availability, moderate cost, and lack of ionizing radiation 1
For nodules detected by ultrasound, further investigation depends on the size of the lesion, with nodules <1 cm requiring ultrasound follow-up every 3-4 months, nodules 1-2 cm requiring evaluation with two different imaging modalities, and nodules >2 cm requiring evaluation with one advanced imaging modality 1, 2, 3, 4

The National Comprehensive Cancer Network recommends the use of MRI with extracellular contrast agent, which has a sensitivity of 83.1% and accuracy of 86.6% for diagnosing liver cancer 2
The Journal of the American College of Radiology suggests that MRI with hepatobiliary agent has a sensitivity of 71.2% and accuracy of 76.5% for diagnosing liver cancer 5
The Clinical and Molecular Hepatology journal reports that contrast-enhanced ultrasound (CEUS) can be used as a second-line exam with a sensitivity of 84% and positive predictive value of 89% for diagnosing liver cancer 6, 7

The hallmarks of hepatocellular carcinoma (HCC) on imaging include hypervascularization in the arterial phase and "washout" phenomenon in the portal, late, or hepatobiliary phase 2, 6, 7
MRI with extracellular contrast agent is superior for identifying arterial hypervascularization (97.6% vs 81.5% for CT) and enhanced capsule (85.5% vs 33.9% for CT) 2, 5

The initial step is abdominal ultrasound for all suspected patients, followed by further investigation based on the size of detected nodules 1, 2, 3
For nodules >2 cm, one advanced imaging modality (preferably MRI with extracellular contrast agent) is recommended 1, 2, 3
If results are equivocal, consider contrast-enhanced ultrasound or biopsy 6, 4

The American College of Radiology notes that benign lesions are more frequent than metastases, even in patients with known malignancy (51% to 80% of lesions <1-1.5 cm are benign) 5
The Journal of the American College of Radiology recommends considering local equipment availability, radiological expertise, and patient-related factors (renal insufficiency, pacemakers, contrast allergies) when choosing imaging modalities 5
The Clinical and Molecular Hepatology journal advises against relying solely on ultrasound results for a definitive diagnosis of malignant lesions and to be cautious in patients with cirrhosis due to vascular disorders or associated liver disease 1, 6, 7

The American College of Radiology recommends that multiphase CT with IV contrast and MRI with IV contrast are equivalent alternatives for characterizing indeterminate liver lesions in patients with normal liver without known malignancy, with either modality providing sufficient diagnostic information to guide management 8, 9, 10
For patients with known extrahepatic malignancy, MRI with IV contrast is preferred over CT for lesions of any size, as it demonstrates superior sensitivity for detecting metastases, particularly lesions <1 cm 8, 9, 10, 11
The American College of Radiology designates MRI and CT as "usually appropriate" with equal appropriateness ratings for lesions >1 cm without malignancy 8

MRI provides superior lesion characterization compared to CT, with higher sensitivity for subcentimeter lesions, particularly in chronic liver disease 9
MRI with hepatobiliary agents provides additional hepatocyte-specific information, which can aid in lesion characterization 11

For lesions <1 cm with known malignancy, MRI with IV contrast is recommended 10
For lesions >1 cm without malignancy, either MRI or CT is acceptable 8, 9
For lesions in cirrhotic liver, MRI is preferred, but CT is also acceptable 8, 10

Multiphase imaging is mandatory for both CT and MRI to achieve diagnostic accuracy, with single-phase studies being inadequate 8, 11, 12
Thin slice reconstruction (≤5 mm) improves lesion detection and characterization 12
Portal venous phase provides the highest sensitivity for most lesion detection 12

Relying on noncontrast or single-phase CT has limited sensitivity and requires repeat imaging with proper multiphase technique 8, 11
CT has significantly lower sensitivity for hypovascular metastases (74%) compared to hypervascular lesions 11
Peripheral ring enhancement on arterial phase has a 98% positive predictive value for malignancy, but must be distinguished from perilesional enhancement seen in benign lesions 12

Contrast-enhanced ultrasound (CEUS) can correctly characterize 95% of lesions overall and 98% of metastases when initial cross-sectional imaging is indeterminate 9
Image-guided biopsy may be necessary, though it is limited for subcentimeter lesions 9